医学
拜瑞妥
阿哌沙班
达比加群
依杜沙班
围手术期
静脉血栓栓塞
重症监护医学
心房颤动
外科
麻醉
华法林
血栓形成
内科学
作者
James D. Douketis,Alex C. Spyropoulos
出处
期刊:JAMA
[American Medical Association]
日期:2024-08-12
标识
DOI:10.1001/jama.2024.12708
摘要
Direct oral anticoagulants (DOACs), comprising apixaban, rivaroxaban, edoxaban, and dabigatran, are commonly used medications to treat patients with atrial fibrillation and venous thromboembolism. Decisions about how to manage DOACs in patients undergoing a surgical or nonsurgical procedure are important to decrease the risks of bleeding and thromboembolism.
科研通智能强力驱动
Strongly Powered by AbleSci AI